AIMC Topic: Drug Discovery

Clear Filters Showing 1131 to 1140 of 1566 articles

Is Multitask Deep Learning Practical for Pharma?

Journal of chemical information and modeling
Multitask deep learning has emerged as a powerful tool for computational drug discovery. However, despite a number of preliminary studies, multitask deep networks have yet to be widely deployed in the pharmaceutical and biotech industries. This lack ...

Machine-Learning-Assisted Approach for Discovering Novel Inhibitors Targeting Bromodomain-Containing Protein 4.

Journal of chemical information and modeling
Bromodomain-containing protein 4 (BRD4) is implicated in the pathogenesis of a number of different cancers, inflammatory diseases and heart failure. Much effort has been dedicated toward discovering novel scaffold BRD4 inhibitors (BRD4is) with differ...

Predicting anatomic therapeutic chemical classification codes using tiered learning.

BMC bioinformatics
BACKGROUND: The low success rate and high cost of drug discovery requires the development of new paradigms to identify molecules of therapeutic value. The Anatomical Therapeutic Chemical (ATC) Code System is a World Health Organization (WHO) proposed...

Hybridizing Feature Selection and Feature Learning Approaches in QSAR Modeling for Drug Discovery.

Scientific reports
Quantitative structure-activity relationship modeling using machine learning techniques constitutes a complex computational problem, where the identification of the most informative molecular descriptors for predicting a specific target property play...

Chemical Space Mimicry for Drug Discovery.

Journal of chemical information and modeling
We describe a new library generation method, Machine-based Identification of Molecules Inside Characterized Space (MIMICS), that generates sets of molecules inspired by a text-based input. MIMICS-generated libraries were found to preserve distributio...

DrugClust: A machine learning approach for drugs side effects prediction.

Computational biology and chemistry
BACKGROUND: Identification of underlying mechanisms behind drugs side effects is of extreme interest and importance in drugs discovery today. Therefore machine learning methodology, linking such different multi features aspects and able to make predi...

Drug repositioning based on triangularly balanced structure for tissue-specific diseases in incomplete interactome.

Artificial intelligence in medicine
Finding new uses for existing drugs has become a new strategy for decades to treat more patients. Few traditional approaches consider the tissue specificities of diseases. Moreover, disease genes, drug targets and protein interaction (PPI) networks r...

Shared Consensus Machine Learning Models for Predicting Blood Stage Malaria Inhibition.

Journal of chemical information and modeling
The development of new antimalarial therapies is essential, and lowering the barrier of entry for the screening and discovery of new lead compound classes can spur drug development at organizations that may not have large compound screening libraries...

CATTLE (CAncer treatment treasury with linked evidence): An integrated knowledge base for personalized oncology research and practice.

CPT: pharmacometrics & systems pharmacology
Despite the existence of various databases cataloging cancer drugs, there is an emerging need to support the development and application of personalized therapies, where an integrated understanding of the clinical factors and drug mechanism of action...

Multi-Assay-Based Compound Prioritization via Assistance Utilization: A Machine Learning Framework.

Journal of chemical information and modeling
Effective prioritization of chemical compounds that show promising bioactivities from compound screenings represents a first critical step toward identifying successful drug candidates. Current development on computational approaches for compound pri...